FTSE set for higher open HSBC revamp in focus

Whilst stocks on Wall Street saw their worst session in a month, European bourses are pointing to a mildly stronger start.

Charts (2)

Whilst stocks on Wall Street saw their worst session in a month, European bourses are pointing to a mildly stronger start. Upbeat Chinese data is managing to distract investors, at least for now, even as covid cases continue to surge across the US and Europe and in the absence of additional fiscal stimulus from the US.

Chinese factory profits rose for a fifth straight month in September and economic growth roared back to life in South Korea. Profits at Chinese industrial firms rose 10.1% year on year in September, down from the 19.1% growth recorded in August, but still a solid reading as strong exports, pent up demand and government stimulus keep the recovery in motion. All in all, data from Asia is improving which is helping to off set nervousness surrounding rising covid numbers in Europe and US. China’s 14th Five Yer Plan will be in focus.

Investors are unnerved by the surging number of covid cases which are dampening the economic recovery outlook. News on Monday that talks over a coronavirus relief package have slowed could keep the lid on gains, although House Speaker Nancy Pelosi remans upbeat that an agreement can still be made before the US elections. Given that talks have been deadlocked for months and that the elections are less than a week away this seems a rather ambitious expectation.

HSBC revamp as profits fall 35%
Banks will be in focus after HSBC reported a less than feared 35% decline in quarterly profits amid an easing in bad loan provisions and an improvement in the outlook for its main markets. HSBC also announce significant changes to its business, including moving away from net interest income as a main source of income towards a fee based focused business, whilst also accelerating plans to reduce the bank’s size and slash costs. This marks a huge shift in strategy but one that make absolute sense given the rock bottom interest rates that have dominated the banking scene for years and are look set to stay for the foreseeable future.

HSBC reported pre-tax profit of $3.1 billion in Q3, above $2.07 billion forecast. HSBC also announced hat it expected bad loan provisions for the year to be towards the lower end of guidance of $8 - $13 billion. The stock listed in Hong Kong trades +5%.  

HSBC follows Barclays in reporting an improved picture for bad loan provisions. This bodes well for Lloyds and NatWest which are due to report later this week.

FTSE Chart


More from FTSE 100

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.